Novo Nordisk stock is having a rough week after that Hims & Hers Super Bowl ad
Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...
Kingsview Wealth Management LLC Has $425,000 Position in Novo Nordisk A/S (NYSE:NVO)
Kingsview Wealth Management LLC reduced its holdings in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 76.9% during the 4th quarter, according to the company in its most recent 13F filing with ...
Trump’s Tariffs Could Worsen Europe’s Economic Slowdown
The trade threats could reduce exports to the United States and dampen investment in Europe, dealing a blow to growth at a ...
Hims & Hers markets itself in a very 2025 way: by picking a fight
Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.
Trump delays a sweeping reciprocal tariff plan as global markets rally
US President Donald Trump signed a Presidential memo on reciprocal tariffs to order his administration to investigate the ...
Novo Nordisk Beat Expectations in Q4 and a Huge Catalyst Could Be Coming Soon
Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...
JD Supra2h
Mintz IRA Update — A Circuit Win and the End of Chevron Deference Could Shift Tides in Drug Price Negotiation Program Challenges
As detailed in our previous updates, the IRA’s Medicare Drug Price Negotiation Program (the Negotiation Program or Program), ...
Medindia13h
Global Artificial Kidney Market to Show Positive Growth at a CAGR of ~13% by 2032 | DelveInsight
Artificial Kidney Market Report Introduction 2 Artificial Kidney Market Executive Summary 3 Competitive Landscape ...